Phthalazinone-based lactams and cyclic ureas as ROCK2 selective inhibitors.
Hu, Z., Sitkoff, D., Glunz, P.W., Zou, Y., Wang, C., Muckelbauer, J.K., Adam, L.P., Wexler, R.R., Quan, M.L.(2023) Bioorg Med Chem Lett 88: 129304-129304
- PubMed: 37119973 
- DOI: https://doi.org/10.1016/j.bmcl.2023.129304
- Primary Citation of Related Structures:  
8GDS - PubMed Abstract: 
Derivatives of lactam, cyclic urea and carbamate were explored as aniline amide replacements in a series of phthalazinone-based ROCK inhibitors. Potent ROCK2 inhibitors such as 22 were identified with excellent overall kinase selectivity as well as good isoform selectivity over ROCK1.
Organizational Affiliation: 
Research & Early Development, Bristol Myers Squibb, P.O. Box 5400, Princeton, NJ 08543-5400, USA. Electronic address: zilun.hu@bms.com.